Canaccord Genuity Reiterates a 'Buy' on Brightpoint (CELL); AT&T (T) Withdraws Bid for T-Mobile - Improves 2012 Logistics Visibility
Tweet
Share
E-mailGet Alerts CELL Hot Sheet
Price: $1.00 --0%
Rating Summary:
0 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Rating Summary:
0 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Brightpoint (NASDAQ: CELL) price target of $14.00.
Canaccord analyst, T. Michael Walkley, said, "AT&T (NYSE: T) withdrew its $39B bid to purchase T-Mobile under mounting regulatory opposition. As a result, we believe Brightpoint should see increased visibility into its logistics business for 2012 as T-Mobile is a significant forward- and reverse-logistics customer. Further, we believe an increasing mix of smartphones globally should increase opportunities for Brightpoint’s logistics services and raise ASPs in the company’s distribution business, and both should increase gross profit dollars."
For an analyst ratings summary and ratings history on Brightpoint click here. For more ratings news on Brightpoint click here.
Shares of Brightpoint closed at $9.14 yesterday.
Canaccord analyst, T. Michael Walkley, said, "AT&T (NYSE: T) withdrew its $39B bid to purchase T-Mobile under mounting regulatory opposition. As a result, we believe Brightpoint should see increased visibility into its logistics business for 2012 as T-Mobile is a significant forward- and reverse-logistics customer. Further, we believe an increasing mix of smartphones globally should increase opportunities for Brightpoint’s logistics services and raise ASPs in the company’s distribution business, and both should increase gross profit dollars."
For an analyst ratings summary and ratings history on Brightpoint click here. For more ratings news on Brightpoint click here.
Shares of Brightpoint closed at $9.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $145 at Evercore ISI
- Spotify (SPOT) PT Raised to $340 at Evercore ISI following strong Q1 results
- Citi Reiterates Buy Rating on Lam Research (LRCX)
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
